2‐Phenyloxazole‐4‐carboxamide as New Scaffold for Selective Inhibition of Human Monoamine Oxidase B

ChemMedChem - United Kingdom
doi 10.1002/cmdc.201900261
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Cover Feature: 2‐Phenyloxazole‐4‐carboxamide as a Scaffold for Selective Inhibition of Human Monoamine Oxidase B (ChemMedChem 18/2019)

ChemMedChem
Organic ChemistryMolecular MedicinePharmacologyBiochemistryToxicologyDrug DiscoveryPharmaceutics
2019English

Monoamine Oxidase Inhibition

Biochemical Society Transactions
Biochemistry
1994English

Monoamine Oxidase and Its Inhibition.

Annals of Internal Medicine
Internal MedicineMedicine
1977English

Synthesis and Evaluation of Iodinated Benzamide Derivative as Selective and Reversible Monoamine Oxidase B Inhibitors.

Chemical and Pharmaceutical Bulletin
MedicineDrug DiscoveryChemistry
1992English

4-Aryliden-2-Methyloxazol-5(4h)-One as a New Scaffold for Selective Reversible MAGL Inhibitors

Journal of Enzyme Inhibition and Medicinal Chemistry
MedicineDrug DiscoveryPharmacology
2015English

Pharmacodynamics of Lazabemide, a Reversible and Selective Inhibitor of Monoamine Oxidase B.

British Journal of Clinical Pharmacology
Pharmacology
1994English

Tight-Binding Inhibition of Human Monoamine Oxidase B by Chromone Analogs: A Kinetic, Crystallographic, and Biological Analysis

English

2-Acetylphenol Analogs as Potent Reversible Monoamine Oxidase Inhibitors

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2015English

Differential Inhibition of Neuronal and Extraneuronal Monoamine Oxidase

Neuropsychopharmacology
PsychiatryMental HealthPharmacology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy